Changeflow GovPing Healthcare & Life Sciences Phase 4 ICG Study Tests Testicular Torsion Dete...
Routine Notice Added Final

Phase 4 ICG Study Tests Testicular Torsion Detection

Favicon for changeflow.com ClinicalTrials.gov Studies
Detected
Email

Summary

A Phase 4 clinical trial (NCT07545278) is investigating whether indocyanine green (ICG) fluorescence imaging and near-infrared spectroscopy can safely and accurately detect testicular torsion in children and young people, potentially reducing unnecessary surgical explorations. The study notes that up to 85% of children undergoing surgical exploration for suspected torsion will not have the condition. Enrollment opens April 22, 2026, with participants receiving an ICG fluorescence injection followed by image capture. The trial aims to eliminate missed torsions while reducing unnecessary surgeries.

“Testicular torsion is a time critical condition for children and young people (CYP).”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 715 changes logged to date.

What changed

A Phase 4 clinical trial has been registered on ClinicalTrials.gov under NCT07545278, studying the use of indocyanine green (ICG) fluorescence injection combined with near-infrared spectroscopy image capture as a diagnostic tool for testicular torsion in children and young people. The trial addresses a critical clinical gap: there are currently no reliable non-invasive diagnostic tests for torsion, and up to 85% of surgical explorations performed for suspected torsion yield no finding. Investigators will assess whether ICG imaging can reduce unnecessary surgeries while ensuring no torsions are missed.

For clinical investigators and healthcare providers involved in pediatric urology or emergency medicine, this trial represents an emerging diagnostic approach to evaluate. Sites planning to participate should ensure institutional review board (IRB) approvals and patient enrollment processes are in place ahead of the April 22, 2026 start date.

Scheduled event

Date
2026-04-22

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Is ICG Imaging Safe and Accurate to Predict Testicular Torsion?

Phase 4 NCT07545278 Kind: PHASE4 Apr 22, 2026

Abstract

Testicular torsion is a time critical condition for children and young people (CYP). It is difficult to diagnose without an operation. Missing it means the child will lose a testicle. There are no good diagnostic tests, only tests that delay the child's journey to theatre, which puts them at further risk of losing the testicle. Most boys with a painful testicle get a surgical exploration to see if it is torsion and to twist and fix it. Up to 85% of children having surgery will not have torsion. They will have something they didn't need surgery for. We want to see whether a new, low risk, fast investigation could be used to diagnose the problem, meaning no torsions are missed and less children have unnecessary surgery.

Conditions: Torsion Testis, Scrotum Disease

Interventions: Indocyanine green fluorescence injection and near infra red spectroscopy image capture

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Clinical investigators Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Clinical trial Medical imaging Diagnostic device study
Geographic scope
United States US

Taxonomy

Primary area
Public Health
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!